NCI (NCIT) & The Competition Head to Head Comparison
NCI (NASDAQ: NCIT) is one of 185 publicly-traded companies in the “IT Services & Consulting” industry, but how does it weigh in compared to its competitors? We will compare NCI to similar businesses based on the strength of its institutional ownership, valuation, analyst recommendations, risk, profitability, earnings and dividends.
This table compares NCI and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a summary of recent ratings and target prices for NCI and its competitors, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
NCI presently has a consensus target price of $18.33, indicating a potential downside of 8.33%. As a group, “IT Services & Consulting” companies have a potential downside of 10.67%. Given NCI’s higher probable upside, research analysts plainly believe NCI is more favorable than its competitors.
Earnings & Valuation
This table compares NCI and its competitors revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|NCI Competitors||$2.79 billion||$288.44 million||311.21|
NCI’s competitors have higher revenue and earnings than NCI. NCI is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Institutional and Insider Ownership
38.6% of NCI shares are owned by institutional investors. Comparatively, 63.0% of shares of all “IT Services & Consulting” companies are owned by institutional investors. 45.4% of NCI shares are owned by insiders. Comparatively, 16.5% of shares of all “IT Services & Consulting” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Risk and Volatility
NCI has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500. Comparatively, NCI’s competitors have a beta of 1.14, suggesting that their average stock price is 14% more volatile than the S&P 500.
NCI competitors beat NCI on 7 of the 12 factors compared.
NCI, Inc. is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration. The Company helps its clients to navigate the range of cloud, Everything-as-a-Service (EaaS), capacity services and virtualization options available. The Company provides its customers the full lifecycle of cybersecurity services, including policy and planning, compliance, identity and access management, training, education, awareness and enterprise security operations.
Receive News & Ratings for NCI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCI and related companies with MarketBeat.com's FREE daily email newsletter.